BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 20, 2001
View Archived Issues
HIV vaccine candidate evaluated in phase I trials
Read More
Lundbeck's psychopharmacological drug pipeline
Read More
Neurological drugs in Lundbeck's pipeline
Read More
Analysis of study results with topiramate in diabetic neuropathic pain
Read More
Human testing of injectable urethral bulking agent in progress
Read More
Organon plans to continue development of the Ampakine Org-24448
Read More
Novo Nordisk's rapid-acting insulin analogue now available in U.S.
Read More
More flexible and personalized therapy now possible with NeoRecormon
Read More
TAK-083 highly effective in the laboratory and in animals against H. pylori
Read More
Free I2 as an effective oxidant in human sperm
Read More
ATLAS study: sequence of events in heart failure progression and protective effects of lisinopril
Read More
Allovectin-7 phase III registration trial in metastatic melanoma now fully enrolled
Read More
Longer acting treatment for anemia in chronic renal failure cleared for U.S. launch
Read More
Amgen elects not to develop Guilford's neuroimmunophilin ligands
Read More
Muscarinic receptor binding profile of YM-905 correlated with pharmacological activity
Read More
Tiagabine as a potential treatment option for overactive bladder
Read More
Taxanes with potent antitumor activity reported by Florida State
Read More
New antimycobacterial compounds from Genzyme interfere with cell wall biosynthesis
Read More
Bayer and Millennium announce identification of 140 disease-relevant drug targets
Read More
Nippon Kayaku prepares new agents for use in photochemical therapy of tumors
Read More
Pharmos expands pivotal phase III trial of dexanabinol into U.K.
Read More
First evidence that overexpression of dopamine D2 receptor reduces alcohol intake
Read More
Erythromycin derivatives identified by Hokuriku active against H. pylori
Read More
Two series of factor Xa inhibitors disclosed recently by Cor
Read More
